A phase Ib/IIa randomized pilot study to investigate the safety and tolerability of autologous T-cells with enhanced T-cell receptors specific to NY-ESO-1/LAGE-1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer Meeting Abstract
| Authors: | Reckamp, K. L.; Akerley, W.; Edelman, M. J.; Halmos, B.; He, K.; Johnson, M.; Mudad, R.; Neal, J. W.; Owonikoko, T. K.; Patel, J. D.; Patel, S. P.; Riess, J. W.; Sacher, A. G.; Turcotte, S.; Villaruz, L. C.; Zauderer, M. G.; Farsaci, B.; Hasan, A.; Patel, R.; Wu, Y.; Chisamore, M.; Lam, V. |
| Abstract Title: | A phase Ib/IIa randomized pilot study to investigate the safety and tolerability of autologous T-cells with enhanced T-cell receptors specific to NY-ESO-1/LAGE-1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer |
| Meeting Title: | 110th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2019 Mar 29-Apr 3 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-07-01 |
| Language: | English |
| ACCESSION: | WOS:000488129900201 |
| DOI: | 10.1158/1538-7445.Am2019-ct225 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT225 -- Source: Wos |
